Partner Content Partner Content Interview with Chair Lynne Ensor at Microbiology Boston Conf... Chair Lynne Ensor speaks about coronvirus
Partner Content Partner Content SMi’s Pharma Microbiology in Boston 2-day event what to expe... SMi’s Pharmaceutical Microbiology in Boston
Partner Content Partner Content Co-Chairs invitation to SMi’s 9th Annual Pharmaceutical Micr... Co-Chairs invitation to SMi’s Pharma Microbiology
Partner Content Partner Content Industry Gathers Next Week at Pharmaceutical Microbiology Ea... Last chance to register
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
